The Ebola Vaccine, Iatrogenic Injuries, and Legal Liability

1. Kelland K, Hirschler, B. Fixing 'Ebolanomics' in pursuit of vaccines and drugs. Reuters. 2014 Oct 14. http://www.reuters.com/article/2014/10/23/us-health-ebola-economics-analysis-idUSKCN0IC1QE20141023.

2. Surowiecki J. Ebolanomics. The New Yorker. 2014 Aug 25. http://www.newyorker.com/magazine/2014/08/25/ebolanomics.

3. Monahan J, Halabi S. Legal preparedness and Ebola vaccines. The Lancet. 2015;386(9991):338–9.

4. World Health Organization. Main operational lessons learnt from the WHO pandemic influenza A (H1N1) vaccine deployment initiative. A report of a WHO meeting held in Geneva, Switzerland 13–15 December 2010. Report. 2011.

5. World Health Organization. Report of the WHO pandemic influenza A (H1N1) vaccine deployment initiative. 2012. Geneva: WHO.

6. Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. The Lancet. 2015 Aug 29;386(9996):857–66.

7. Looker C, Kelly H. No-fault compensation following adverse events attributed to vaccination: a review of international programmes. Bulletin of the World Health Organization. 2011;89(5):371–8. doi: 10.2471/BLT.10.081901 21556305

8. National Childhood Vaccine Injury Act of 1986 (as amended) 42 U.S.C. §§ 300aa-1 to 300aa-34.

9. Public Readiness and Emergency Preparedness Act, Pub. L. No. 109–148, Division C, 119 Stat. 2818 (December 30, 2005).

10. Adam, Abudu v. Ledesma-Cadhit et al, 2014 ONSC 5726 (CanLII)

11. HIH Casualty & General Insurance Ltd. v Chase Manhattan Bank, [2003] UKHL 6.

12. General Assembly of the United Nations. Conventions on the privileges and immunities of the United Nations. 1946. Cited 2014 Dec 12. http://www.un.org/en/ethics/pdf/convention.pdf.

13. Barzilay EJ, Schaad N, Magloire R, Mung KS, Boncy J, Dahourou GA, et al. Cholera surveillance during the Haiti epidemic—the first 2 years. New England Journal of Medicine. 2013;368(7):599–609. doi: 10.1056/NEJMoa1204927 23301694

14. Cravioto A, Lanata CF, Lantagne DS, Balakrish Nair G. Final report of the independent panel of experts on the cholera outbreak in Haiti. Final Report of the Independent Panel of Experts on the Cholera Outbreak in Haiti 2011. http://reliefweb.int/report/haiti/final-report-independent-panel-experts-cholera-outbreak-haiti

15. Orata FD, Keim PS, Boucher Y. The 2010 cholera outbreak in Haiti: how science solved a controversy. PLoS Pathog. 2014;10(1):e1003967.

16. O'Brien, P. Letter to Mr. Concannon from United Nations headquarters. 2013 Feb 21. Cited 2014 Dec 12. http://opiniojuris.org/wp-content/uploads/LettertoMr.BrianConcannon.pdf.

17. Nesirky, M. Highlights of the noon briefing—Haiti: U.N. says cholera claim not receivable, secretary-general reiterates sympathy for suffering. 2013. Cited 2014 Dec 12. http://www.un.org/sg/spokesperson/highlights/index.asp?HighD=2/21/2013.

18. Delma Georges, et al. v. United Nations, et al. U.S. District Court (SDNY), 13-CV-7146 (JPO), 9 January 2015.

19. Global Health Justice Partnership, L’Association Haïtienne de Droit de l’Environnement. Peacekeeping without Accountability: The United Nations’ Responsibility for the Haitian Cholera Epidemic. Final Report. 2013. http://canadahaitiaction.ca/sites/default/files/Cholera%20Yale%20U%20report%20July%202013.pdf

20. Evans G. Vaccine injury compensation programs worldwide. Vaccine. 1999;17:S25–S35. 10559532

21. Keelan JE, Wilson K. Designing a No-fault Vaccine-injury Compensation Programme for Canada: Lessons Learned from an International Analysis of Programmes: Munk School of Global Affairs, University of Toronto; 2011. http://munkschool.utoronto.ca/wp-content/uploads/2012/07/Keelan-Wilson_NoFaultVaccine_CPHS_2011.pdf

22. Evans G. Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002. Clinical infectious diseases. 2006;42(Supplement 3):S130–S7.

23. Keelan J, Wilson K. Balancing vaccine science and national policy objectives: lessons from the National Vaccine Injury Compensation Program Omnibus Autism Proceedings. American journal of public health. 2011;101(11):2016. doi: 10.2105/AJPH.2011.300198 21940934

24. Meyers PH. Fixing the Flaws in the Federal Vaccine Injury Compensation Program. Administrative Law Review. 2011 : 785–851.

25. Engstrom Nora F, Exit, Advserialism and the Stubborn Persistence of Tort. Journal of Tort Law 2013;6(1–2):75–114.

26. Santé et Services sociaux. Québec's compensation for victims of vaccination program. 2014. Cited 2014 Dec 12. http://www.msss.gouv.qc.ca/sujets/santepub/vaccination/index.php?indemnisation_en.

27. World Health Organization. Causality assessment of adverse events following immunization. 2001. Cited 2014 Dec 12. http://www.who.int/vaccine_safety/causality/en/.

28. GOV.UK. Vaccine Damage Payment. 2014. Cited 2014 Dec 12. https://www.gov.uk/vaccine-damage-payment/overview.

29. World Health Organization. WHO High-level meeting on Ebola vaccines access and financing. Summary Report. 2014 Oct 24. Geneva: WHO.

30. Avian and Human Influenza Facility. Quarterly report to the donors for the period January 1st through March 31st, 2013. Working Paper. The World Bank. 2013 Mar 31.

31. World bank group president calls for new global pandemic emergency facility. The World Bank; 2014. Cited December 12, 2014. http://www.worldbank.org/en/news/press-release/2014/10/10/world-bank-group-president-calls-new-global-pandemic-emergency-facility